A Phase I/II Study of Cyclophosphamide and Topotecan in Patients with High-Risk Malignancies Undergoing Autologous Hematopoietic Cell Transplantation: The St. Jude Long-term Follow-up

Fifty-eight consecutive children with high-risk malignancies were treated with cyclophosphamide and targeted topotecan followed by autologous hematopoietic cell transplantation (AHCT) in a phase I/II IRB-approved study. Twelve participants enrolled in phase I; 5 received dose level 1 of topotecan 3m...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Bone Marrow Transplant
المؤلفون الرئيسيون: Kasow, Kimberly A., Stewart, Clinton F., Barfield, Raymond C., Wright, Nancy L., Li, Chenghong, Srivastava, Deo Kumar, Leung, Wing, Horwitz, Edwin M., Bowman, Laura C., Handgretinger, Rupert, Hale, Gregory A.
التنسيق: Artigo
اللغة:Inglês
منشور في: 2012
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4893814/
https://ncbi.nlm.nih.gov/pubmed/22426752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2012.51
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة